Sharemaestro Newsreel

How Higher Sales, Lower EPS And New Guidance At McKesson (MCK) Has Changed Its Investment Story

On August 5, 2026, McKesson Corporation reported first-quarter fiscal 2027 results showing sales of US$105.38 billion, higher than a year earlier, while net income and earnings per share from continuing operations declined year-on-year. Alongside these results, McKesson completed a large portion of its long-running …

First Trust Advisors LP Invests $2.26 Million in Advance Auto Parts, Inc. $AAP

First Trust Advisors LP has initiated a new position in Advance Auto Parts, investing approximately $2.26 million for 42,916 shares. Despite this new investment, analysts maintain a cautious outlook on AAP, with an average "Hold" rating and a target price slightly above its current …

111 Inc (YI) Stock News Today

This article provides current stock information for 111 Inc (YI), including its latest stock price, market capitalization, and a note that more news is coming soon. It also lists various financial and analytical tools available on the TradingKey platform for monitoring the stock. The …

Synergy CHC Corp (SNYR) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Synergy CHC Corp (SNYR), detailing its current earnings forecast score, average price target, and analyst ratings. It highlights that the company ranks 58 out of 156 in the Pharmaceuticals industry, with two analysts recommending a "Buy" trend. …

Catalyst Watch: Inflation reads, AMAT earnings, Google Pixel event, and MLB on Netflix

[Lower Manhattan Cityscape] Art Wager/E+ via Getty Images Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MONDAY - AUGUST 10 * …

Will Pharma and Specialty Demand Boost Cardinal Health's Q4 Results?

Cardinal Health (CAH) is set to announce its fourth-quarter fiscal 2027 results, with analysts expecting strong year-over-year growth in sales and earnings per share, driven primarily by its Pharmaceutical and Specialty Solutions business. The company's focus on high-margin specialty healthcare services and strategic investments …

XRAY Stock Falls Despite Q2 Earnings Beat, Wellspect Drives Sales

DENTSPLY SIRONA Inc. XRAY reported second-quarter 2026 adjusted earnings per share (EPS) of 52 cents, down 1.6% year over year on an actual-value basis. The bottom line beat the Zacks Consensus Estimate of 36 cents by 44.4%. GAAP EPS in the quarter was 18 …

McKesson signals next phase for MMS with new name

McKesson's Medical-Surgical Solutions business will formally operate as Wellverse starting in January 2027, according to CEO Brian Tyler. This rebranding aims to establish a distinct market identity and reflects the company's ongoing phased transition towards separation. The company also reported Q1 fiscal year 2027 …

10x Genomics Q2 Earnings & Revenues Beat Estimates, Gross Margin Up

10x Genomics TXG reported a second-quarter 2026 loss of 14 cents per share against earnings of 28 cents in the year-ago quarter, representing a 150% year-over-year decline. Still, the figure beat the Zacks Consensus Estimate of a loss of 23 cents by 38.1%. Revenues …

Rigetti Q2 Earnings Miss Estimates on Higher Costs, Revenue Beat

Rigetti Computing RGTI reported second-quarter 2026 adjusted loss per share of 5 cents, wider than 4 cents in the prior-year quarter. The metric also missed the Zacks Consensus Estimate of earnings by 66.7%. GAAP loss per share in the reported quarter was 16 cents …

Cosmos Health Inc (COSM) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Cosmos Health Inc (COSM), noting that no earnings forecast score is currently available, but the Pharmaceuticals industry average is 7.86. Analysts have set an average price target of $3.00 for COSM, representing a significant upside. Key financial …

Cencora Inc. stock underperforms Friday when compared to competitors

Cencora Inc. (COR) shares dropped 1.40% on Friday, closing at $320.46, despite a generally positive trading day for the broader market. This underperformance broke a two-day winning streak for the stock. The S&P 500 Index and the Dow Jones Industrial Average both saw gains …

Henry Schein Recasts Its Future Around AI, Simpler Leadership and Faster Execution

Henry Schein is transforming its business by embedding AI into customer-facing applications and internal operations, simplifying its leadership structure, and focusing on faster execution. CEO Fred Lowery outlined this ambitious strategy following stronger second-quarter results and a significant leadership reorganization. The healthcare distributor aims …

PensionDanmark Pensionsforsikringsaktieselskab Grows Stake in McKesson Corporation $MCK

PensionDanmark Pensionsforsikringsaktieselskab increased its stake in McKesson Corporation by 8.9% in the second quarter, bringing its total holdings to 30,850 shares valued at $23.3 million. This increase comes as McKesson reported strong fiscal first-quarter results, with adjusted EPS and revenue exceeding analyst expectations, and …

McKesson (MCK) Stock Pauses Despite Higher Guidance And EPS Strength

CAH|Cardinal Health Inc|Price:236.400|Chg%:-1.190

Akso Health Group (AHG) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Akso Health Group (AHG), focusing on future EPS and revenue growth estimates. It includes a current stock quote, market capitalization, and a list of peer companies for comparison. The data was updated on August 8, 2026.

McKesson Medical-Surgical is becoming Wellverse, keeping RVA headquarters

McKesson Medical-Surgical, a major healthcare employer in Richmond, is rebranding as Wellverse in January 2027 as it moves towards becoming an independent, publicly traded company. The new name reflects its mission to unify healthcare supply and support, allowing providers to focus on patient care. …

McKesson Corporation Stock 12‑Month Price Target Raised to $985.4, Implies 12% Upside

Analysts have raised the 12-month average price target for McKesson Corporation (MCK) stock to $985.4, up from $953.07, implying a 12% upside based on the Aug. 5 closing price. The target range for the stock is between $812 and $1080 per share. The consensus …

Henrico’s McKesson Medical-Surgical plans 2027 IPO

Henrico County-based McKesson Medical-Surgical, a subsidiary of McKesson, announced plans for a 2027 IPO and will rebrand as Wellverse in January 2027. The company, which provides medical supplies and services to over 336,000 customers, was recently valued at $13 billion after selling a minority …

Dentsply Sirona investors brace for earnings amid Medline threat By Investing.com

Dentsply Sirona Inc. is preparing to report second-quarter earnings, facing investor scrutiny over its ability to counter competitive pressure from Medline's expansion into the dental market. Analysts forecast earnings of 35 cents per share and revenue of $889.2 million, representing a significant year-over-year decline. …

Cardinal Health CFO Mary C. Scherer Reports Acquisition of 2,610 Shares via Performance Units

Mary C. Scherer, the Chief Accounting Officer of Cardinal Health Inc., reported the acquisition of 2,610 common shares on August 4, 2026. This acquisition occurred through the vesting of performance share units. The filing was made on August 6, 2026.

Henry Schein Inc. stock underperforms Thursday when compared to competitors

Shares of Henry Schein Inc. (HSIC) fell 1.52% to $88.23 on Thursday, ending a four-day winning streak. This underperformance occurred during a dismal trading session where the S&P 500 Index declined by 0.18% and the Dow Jones Industrial Average dropped by 0.85%.

Mizuho Adjusts Price Target on McKesson to $905 From $885

Mizuho has increased its price target for McKesson (MCK) to $905 from $885, as reported on August 6, 2026. This adjustment follows a series of similar price target updates from other financial institutions on the same day, indicating a potentially shifting outlook for the …

Mckesson Corp Stock (MCK) Moved Down by 3.44% on Aug 6: What Signal Does It Send?

McKesson Corp (MCK) stock fell by 3.44% due to a contraction in operating margins within its U.S. Pharmaceutical segment and management's decision to maintain, rather than raise, full-year earnings guidance. The company also faces challenges from increased capital expenditure, regulatory scrutiny on drug pricing, …

Cardinal Health appoints new Chief Accounting Officer

Cardinal Health has appointed Anita Zielinski as its new Chief Accounting Officer, effective November 5, 2026. Zielinski, who brings extensive experience from Baxter International, Sysco Corporation, and Ernst & Young LLP, will join as Senior Vice President Finance on September 16, ensuring a stable …

FMR LLC discloses 6.6% Henry Schein (HSIC) stake in Schedule 13G filing

FMR LLC and Abigail P. Johnson have reported a beneficial ownership of 6.6% in Henry Schein, Inc. (HSIC) through a Schedule 13G filing. FMR LLC holds sole voting power over 6,786,663.10 shares and sole dispositive power over 7,553,900.88 shares, while Abigail P. Johnson has …

McKesson debuts Wellverse name for Medical-Surgical Solutions business

McKesson has announced that "Wellverse" will be the new name for its future standalone Medical-Surgical Solutions business. This move is part of the company's planned separation, supported by a $2.25 billion Term Loan B facility and a previous $1.25 billion minority interest sale to …

Cardinal Health stock hits all-time high at 243.71 USD

Cardinal Health (CAH) stock reached an all-time high of $243.71, reflecting significant investor confidence and robust market performance with a 55.94% increase over the past year. Despite hitting a new high, InvestingPro analysis suggests the stock remains undervalued relative to its Fair Value. Recent …

McKesson price regains footing - Forecast today - 06-08-2026

McKesson Corporation (MCK) closed higher, continuing its recovery with positive momentum after establishing a higher low. The stock remains in a short-term bullish corrective trend, trading above its 50-day Simple Moving Average, and momentum indicators show a bullish divergence. The outlook is bullish, targeting …

Canandaigua National Bank & Trust Co. Invests $1.56 Million in McKesson Corporation $MCK

Canandaigua National Bank & Trust Co. has invested $1.56 million in McKesson Corporation, purchasing 2,071 shares during the second quarter. McKesson exceeded quarterly expectations with adjusted EPS of $9.93 and revenue of $105.38 billion, and has raised its fiscal 2027 adjusted EPS guidance. The …

Cencora Raises 2026 EPS Outlook After Strong Quarter

Cencora reported strong fiscal third-quarter results, with revenue up 5.1% to $84.8 billion and adjusted diluted EPS increasing 12% to $4.48. The company subsequently raised its fiscal 2026 adjusted EPS guidance to $17.75–$17.95 and repurchased $1 billion in shares. These positive results were influenced …

Jenni Wheeler, Cardinal Health VP, Data Office, Joins CDO Magazine Global Board

Jenni Wheeler, VP of the Data Office at Cardinal Health, has been appointed to CDO Magazine's Global Board. She brings over 20 years of experience in data strategy, advanced analytics, and technology transformation, focusing on operationalizing data to fuel insights and drive business outcomes. …

Cardinal Health (NYSE: CAH) awards 58,738 performance share units to CFO

Cardinal Health (NYSE: CAH) has awarded its Chief Financial Officer, Aaron E. Alt, 58,738 performance share units, which will settle on August 15, 2026. This equity award was granted on August 4, 2026, at a price of $0.0000 per share. Following this transaction, Alt …

Cardinal Health (CAH) awards 17,230 performance units to its CIO

Cardinal Health's Chief Information Officer, Michelle D. Greene, was awarded 17,230 common shares in the form of performance share units. These units, which were granted at no cash purchase price, are set to settle on August 15, 2026. Following this award, Greene directly holds …

McKesson Kicks Off Fiscal 2027 With Solid Results Underpinned by Specialty and Margin Strength

McKesson, a leading pharmaceutical wholesaler, reported solid results for the start of fiscal 2027, driven by strong performance in its specialty segment and robust margins. The company, alongside Cardinal Health and Cencora, forms an oligopoly controlling over 90% of the U.S. drug distribution market. …